Inflammation and clinical repercussions of pleurodesis induced by intrapleural talc administration

Clinics

Volumn 62, Issue 5, 2007, Pages 627-634

  Genofre, Eduardo Henrique ^a   Marchi, Evaldo ^a   Vargas, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Inflammation; Pleura; Pleural effusion; Pleurodesis; Talc

Indexed keywords

TALC;

ANIMAL; HUMAN; INFLAMMATION; METHODOLOGY; PLEURA EFFUSION; PLEURODESIS; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; PLEURAL EFFUSION; PLEURODESIS; TALC;

EID: 36448937854     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322007000500015     Document Type: Review

References (45)

1. Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant pleural effusion. Semi Oncol. 1985;12:54-75.
2. Marchi E, Teixeira LR, Vargas FS. Management of malignancy-associated pleural effusion: current and future treatment strategies. Am J Respir Med. 2003;2:261-73.
3. Bethune N. Pleural poudrage: new technique for deliberate production of pleural adhesions as preliminary to lobectomy. J Thorac Surg. 1935;4:251-61.
4. st ed, Ed Roca, 2004.
5. Wallach HW. Intrapleural tetracycline for malignant pleural effusions. Chest. 1975;68:510-2.
6. Teixeira LR, Vargas FS, Acencio MMP, Bumlai RUM, Antonangelo L, Marchi E. Experimental pleurodesis induced by antibiotics (macrolides or quinolones). Clinics 2006;61:559-64.
7. Bitran JD, Brown C, Desser RK, Kozloff MF, Shapiro C, Billings AA. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol. 1981;16:273-6.
8. Rossi GA, Felletti R, Balbi B, Sacco O, Cosulich E, Risso A, et al. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Am Rev Respir Dis. 1987;135:885-90.
9. Kishi K, Homma S, Sakamoto S, Kawabata M, Tsuboi E, Kohno T, et al. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J, 2004;24:263-6.
10. Marchi E, Vargas FS, Acencio MMP, Antonangelo L, Teixeira LR, Genofre EH, et al. Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits. Chest. 2004;125:2268-77.
11. Vargas FS, Teixeira LR, Antonangelo L, Vaz MAC, Carmo AO, Marchi E, et al. Experimental pleurodesis in rabbits induced by silver nitrate and talc. 1-year follow-up. Chest. 2001;119:1516-20.
12. Gary Lee YC, Malkerneker D, Devin CJ, Thompson PJ, Johnson JE, Lane KB, et al. Comparing transforming growth factor beta-2 and fibronectin as pleurodesing agents. Respirology. 2001;6:281-6.
13. Sartori S, Tassinari D, Ceccotti P, Tombesi P, Nielsen I, Trevisani L, et al. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. J Clin Oncol. 2004;22:1228-33.
14. Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003;88:F531-3.
15. Lang-Lazdunski L, Coonar AS. A prospective study of autologous 'blood patch' pleurodesis for persistent air leak after pulmonary resection. Eur J Cardiothorac Surg. 2004;26:897-900.
16. Cetin B, Koçkaya EA, Atalay C, Akay MT, Cetin A. The efficacy of polidocanol in pleurodesis in rats. Surg Today. 2003;33:688-92.
17. de Campos JR, Vargas FS, Werebe EC, Cardoso P, Teixeira LR, Jatene FB, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801-6.
18. Light RW. Talc for pleurodesis? Chest. 2002;122:1506-8.
19. Sahn SA. Talc should be used for pleurodesis: pro/con editorials. Am J Respir Crit Care Med. 2001;163:2023-6.
20. de Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349:251-2.
21. Rehse DH, Aye RW, Florence MG. Respiratory failure after talc pleurodesis. Am J Surg. 1999;177:437-40.
22. Todd TR, Delarue NC, Ilves R, Pearson FG, Cooper JD, et al. Talc poudrage for malignant pleural effusion. Chest. 1980;78:542-3.
23. Marchi E, Teixeira LR, Vargas FS, Astoul P, Fraticelli A, Robaglia-Schlupp A, et al. Talc for pleurodesis: hero or villain? Chest. 2003;124:416.
24. Van der Heuvel MM, Smith HJ, Barbierato SB, Havenith CE, Beelen RH, Postmus PE. Talc-induced inflammation in the pleural cavity. Eur Resp J. 1998;12:1419-23.
25. Montes JF, Ferrer J, Villarino MA, Baeza B, Crespo M, Garcia-Valero J. Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med. 2003;168:348-55.
26. Li J. Ultrastructural study on the pleural stomata in human. Funct Dev Morphol. 1993;3:277-80.
27. Ferrer J, Montes JF, Villarino MA, Light RW, Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122:1018-27.
28. Werebe EC, Pazetti R, de Campos JR, Fernandez PP, Capelozzi VL, Jatene FB, et al. Systemic distribution of talc after intrapleural administration in rats. Chest. 1999;115:190-3.
29. Fraticelli A, Robaglia-Schlupp A, Riera H, Monjanel-Mouterde S, Cau P, Astoul P. Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest. 2002;122:1737-41.
30. Genofre EH, Vargas FS, Teixeira LR, Acencio MMP, Antonangelo L, Marchi E. Systemic inflammatory acute response in talc pleurodesis using talc of different size particles. Chest. 2004;126:726S.
31. Genofre EH, Vargas FS, Acencio MMP, Antonangelo L, Teixeira LR, Figueiredo VR, et al. Talc pleurodesis: lung dispersion of talc using talc of different size particles. Eur Respir J. 2006;28:740s.
32. Ferrer J, Villarino MA, Tura JM, Traveria A, Light RW. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest. 2001;119:1901-5.
33. Genofre EH, Vargas FS, Antonangelo L, Teixeira LR, Vaz MA, Marchi E, et al. Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc. Lung. 2005;183:197-207.
34. Maskell NA, Gleeson FV, Jones E, Davies RJ. Talc but not tetracycline pleurodesis induces hypoxemia and increased DTPA clearance from the contra-lateral lung. Am J Respir Crit Care Med. 2002;165:B11.
35. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170:377-82.
36. Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest. 2004;125:2356-60.
37. Gary Lee YC. Cytokines in pleural diseases. In Light RW, Lee YC: Textbook of pleural diseases. London: Arnold Publishers; 2003. p. 63-89.
38. Gary Lee YC, Lane KB, Zoia O, Thompson PJ, Light RW, Blackwell TS. Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J. 2003;22:197-202.
39. Sanches C, Marchi E, Romero B, Vargas FS, Panadero FR. Association of the size of talc particles with the occurrence of complications of pleurodesis. Eur Respir J. 2001;18:515-6S.
40. Nasreen N, Mohammed KA, Dowling PA, Ward MJ, Galffy G, Antony VB. Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am J Respir Crit Care Med. 2000;161:595-600.
41. Froudarakis ME, Klimathianaki M, Pougonias M. Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest. 2006;129:356-61.
42. Segura RM, Alegre J, Varela E, Marti R, Suriñach JM, Jufresa J, et al. Interleukin-8 and markers of neutrophil degranulation in pleural effusions. Am J Respir Crit Care Med. 1998;157:1565-72.
43. 2 induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med. 2002;165:88-94.
44. Marchi E, Vargas FS, Acencio MM, Antonangelo L, Genofre EH, Teixeira LR. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur Respir J. 2006;28:929-32.
45. Acencio MMP, Vargas FS, Teixeira LR, Antonangelo L, Marchi E. Are mesothelial cells the key regulators of the acute inflammatory response in talc-induced pleurodesis? Am J Respir Crit Care Med. 2004;169:A618.